Insider Transactions Reported by 20 Insiders of Harpoon Therapeutics, Inc.

Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Harpoon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ansbert Gadicke 10%+ Owner $145,546,185 28 May 2021
New Leaf Ventures III, L.P. 10%+ Owner $21,018,780 11 Jan 2021
Joanne L. Viney Director $483,644 01 Apr 2023
Alan Colowick Director $378,488 01 Apr 2023
Merck & Co., Inc. 10%+ Owner $23,000 11 Mar 2024
Mark Chin Director $0 08 Mar 2024
James B. Bucher Chief Legal Officer 11 Mar 2024
Holger Wesche Chief Scientific Officer 28 Jan 2022
LAUREN P. SILVERNAIL Director 11 Mar 2024
Andrew R. Robbins Director 11 Mar 2024
Leaf Biopharma Opportunities II L.P. New Director, 10%+ Owner 11 Mar 2024
Natalie Sacks Chief Medical Officer 28 Jan 2022
JONATHAN G. DRACHMAN Director 08 Mar 2024
RONALD HUNT Director, 10%+ Owner 08 Mar 2024
Luke Nathaniel Walker Chief Medical Officer 11 Mar 2024
JOSEPH S. BAILES Director 11 Mar 2024
Scott Dunseth Myers Director 11 Mar 2024
JULIA MARIE EASTLAND President and CEO, Director 11 Mar 2024
Georgia Erbez Chief Financial Officer 28 Jan 2022
Frank J. Lanza Principal Fin. & Acctng Ofc. 11 Mar 2024

Recent Insider Transactions by Companies or Individuals for Harpoon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.